Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes - a prospective observational cohort study

Authors: Elsa M Dahlén, Niclas Bjarnegård, Toste Länne, Fredrik H Nystrom, Carl J Östgren

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

Anthropometric measurements are useful in clinical practice since they are non-invasive and cheap. Previous studies suggest that sagittal abdominal diameter (SAD) may be a better measure of visceral fat depots. The aim of this study was to prospectively explore and compare how laboratory and anthropometric risk markers predicted subclinical organ damage in 255 patients, with type 2 diabetes, after four years.

Methods

Baseline investigations were performed in 2006 and were repeated at follow-up in 2010. Carotid intima-media thickness (IMT) was evaluated by ultrasonography and aortic pulse wave velocity (PWV) was measured with applanation tonometry over the carotid and femoral arteries at baseline and at follow-up in a cohort of subjects with type 2 diabetes aged 55–65 years old.

Results

There were significant correlations between apolipoprotein B (apoB) (r = 0.144, p = 0.03), C - reactive protein (CRP) (r = 0.172, p = 0.009) at baseline and IMT measured at follow-up. After adjustment for sex, age, treatment with statins and Hba1c, the associations remained statistically significant. HbA1c, total cholesterol or LDL-cholesterol did not correlate to IMT at follow-up. Baseline body mass index (BMI) (r = 0.130, p = 0.049), waist circumference (WC) (r = 0.147, p = 0.027) and sagittal Abdominal Diameter (SAD) (r = 0.184, p = 0.007) correlated to PWV at follow-up. Challenged with sex, SBP and HbA1c, the association between SAD, not WC nor BMI, and PWV remained statistically significant (p = 0.036). In a stepwise linear regression, entering both SAD and WC, the association between SAD and PWV was stronger than the association between WC and PWV.

Conclusions

We conclude that apoB and CRP, but not LDL-cholesterol predicted subclinical atherosclerosis. Furthermore, SAD was more independent in predicting arterial stiffness over time, compared with WC, in middle-aged men and women with type 2 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Knowles KM, Paiva LL, Sanchez SE, Revilla L, Lopez T, Yasuda MB, Yanez ND, Gelaye B, Williams MA: Waist Circumference, Body Mass Index, and Other Measures of Adiposity in Predicting Cardiovascular Disease Risk Factors among Peruvian Adults. Int J Hypertens. 2011, 2011: 931402.PubMedCentralCrossRefPubMed Knowles KM, Paiva LL, Sanchez SE, Revilla L, Lopez T, Yasuda MB, Yanez ND, Gelaye B, Williams MA: Waist Circumference, Body Mass Index, and Other Measures of Adiposity in Predicting Cardiovascular Disease Risk Factors among Peruvian Adults. Int J Hypertens. 2011, 2011: 931402.PubMedCentralCrossRefPubMed
2.
go back to reference Petersson H, Daryani A, Riserus U: Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovasc Diabetol. 2007, 6: 10-10.1186/1475-2840-6-10.PubMedCentralCrossRefPubMed Petersson H, Daryani A, Riserus U: Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovasc Diabetol. 2007, 6: 10-10.1186/1475-2840-6-10.PubMedCentralCrossRefPubMed
3.
go back to reference Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B: Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004, 27 (8): 2041-2046. 10.2337/diacare.27.8.2041.CrossRefPubMed Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B: Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004, 27 (8): 2041-2046. 10.2337/diacare.27.8.2041.CrossRefPubMed
4.
go back to reference Gustat J, Elkasabany A, Srinivasan S, Berenson GS: Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study. Am J Epidemiol. 2000, 151 (9): 885-891. 10.1093/oxfordjournals.aje.a010292.CrossRefPubMed Gustat J, Elkasabany A, Srinivasan S, Berenson GS: Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study. Am J Epidemiol. 2000, 151 (9): 885-891. 10.1093/oxfordjournals.aje.a010292.CrossRefPubMed
5.
go back to reference Ohrvall M, Berglund L, Vessby B: Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes Relat Metab Disord. 2000, 24 (4): 497-501. 10.1038/sj.ijo.0801186.CrossRefPubMed Ohrvall M, Berglund L, Vessby B: Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes Relat Metab Disord. 2000, 24 (4): 497-501. 10.1038/sj.ijo.0801186.CrossRefPubMed
6.
go back to reference Kahn HS, Simoes EJ, Koponen M, Hanzlick R: The abdominal diameter index and sudden coronary death in men. Am J Cardiol. 1996, 78 (8): 961-964. 10.1016/S0002-9149(96)00479-1.CrossRefPubMed Kahn HS, Simoes EJ, Koponen M, Hanzlick R: The abdominal diameter index and sudden coronary death in men. Am J Cardiol. 1996, 78 (8): 961-964. 10.1016/S0002-9149(96)00479-1.CrossRefPubMed
7.
go back to reference Seidell JC, Andres R, Sorkin JD, Muller DC: The sagittal waist diameter and mortality in men: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord. 1994, 18 (1): 61-67.PubMed Seidell JC, Andres R, Sorkin JD, Muller DC: The sagittal waist diameter and mortality in men: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord. 1994, 18 (1): 61-67.PubMed
8.
go back to reference Laakso M, Lehto S: Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998, 137 (Suppl): S65-S73.CrossRefPubMed Laakso M, Lehto S: Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998, 137 (Suppl): S65-S73.CrossRefPubMed
9.
go back to reference Mehta S, Farmer JA: Obesity and inflammation: a new look at an old problem. Curr Atheroscler Rep. 2007, 9 (2): 134-138. 10.1007/s11883-007-0009-4.CrossRefPubMed Mehta S, Farmer JA: Obesity and inflammation: a new look at an old problem. Curr Atheroscler Rep. 2007, 9 (2): 134-138. 10.1007/s11883-007-0009-4.CrossRefPubMed
10.
go back to reference Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997, 40 (11): 1286-1292. 10.1007/s001250050822.CrossRefPubMed Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997, 40 (11): 1286-1292. 10.1007/s001250050822.CrossRefPubMed
11.
go back to reference Kimberly MM, Cooper GR, Myers GL: An overview of inflammatory markers in type 2 diabetes from the perspective of the clinical chemist. Diabetes Technol Ther. 2006, 8 (1): 37-44. 10.1089/dia.2006.8.37.CrossRefPubMed Kimberly MM, Cooper GR, Myers GL: An overview of inflammatory markers in type 2 diabetes from the perspective of the clinical chemist. Diabetes Technol Ther. 2006, 8 (1): 37-44. 10.1089/dia.2006.8.37.CrossRefPubMed
12.
go back to reference Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007, 115 (4): 459-467. 10.1161/CIRCULATIONAHA.106.628875.CrossRefPubMed Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007, 115 (4): 459-467. 10.1161/CIRCULATIONAHA.106.628875.CrossRefPubMed
13.
go back to reference Lundby-Christensen L, Almdal TP, Carstensen B, Tarnow L, Wiinberg N: Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study. Cardiovasc Diabetol. 2010, 9: 40-10.1186/1475-2840-9-40.PubMedCentralCrossRefPubMed Lundby-Christensen L, Almdal TP, Carstensen B, Tarnow L, Wiinberg N: Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study. Cardiovasc Diabetol. 2010, 9: 40-10.1186/1475-2840-9-40.PubMedCentralCrossRefPubMed
14.
go back to reference Laurent S, Boutouyrie P: Arterial stiffness: a new surrogate end point for cardiovascular disease?. J Nephrol. 2007, 20 (Suppl 12): S45-S50.PubMed Laurent S, Boutouyrie P: Arterial stiffness: a new surrogate end point for cardiovascular disease?. J Nephrol. 2007, 20 (Suppl 12): S45-S50.PubMed
15.
go back to reference Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005, 111 (25): 3384-3390. 10.1161/CIRCULATIONAHA.104.483628.CrossRefPubMed Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005, 111 (25): 3384-3390. 10.1161/CIRCULATIONAHA.104.483628.CrossRefPubMed
16.
go back to reference Wykretowicz A, Gerstenberger P, Guzik P, Milewska A, Krauze T, Adamska K, Rutkowska A, Wysocki H: Arterial stiffness in relation to subclinical atherosclerosis. Eur J Clin Invest. 2009, 39 (1): 11-16. 10.1111/j.1365-2362.2008.02057.x.CrossRefPubMed Wykretowicz A, Gerstenberger P, Guzik P, Milewska A, Krauze T, Adamska K, Rutkowska A, Wysocki H: Arterial stiffness in relation to subclinical atherosclerosis. Eur J Clin Invest. 2009, 39 (1): 11-16. 10.1111/j.1365-2362.2008.02057.x.CrossRefPubMed
17.
go back to reference Dahlen EM, Lanne T, Engvall J, Lindstrom T, Grodzinsky E, Nystrom FH, Ostgren CJ: Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med. 2009, 26 (4): 384-390. 10.1111/j.1464-5491.2009.02693.x.CrossRefPubMed Dahlen EM, Lanne T, Engvall J, Lindstrom T, Grodzinsky E, Nystrom FH, Ostgren CJ: Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med. 2009, 26 (4): 384-390. 10.1111/j.1464-5491.2009.02693.x.CrossRefPubMed
18.
go back to reference Wijkman M, Lanne T, Engvall J, Lindstrom T, Ostgren CJ, Nystrom FH: Masked nocturnal hypertension–a novel marker of risk in type 2 diabetes. Diabetologia. 2009, 52 (7): 1258-1264. 10.1007/s00125-009-1369-9.CrossRefPubMed Wijkman M, Lanne T, Engvall J, Lindstrom T, Ostgren CJ, Nystrom FH: Masked nocturnal hypertension–a novel marker of risk in type 2 diabetes. Diabetologia. 2009, 52 (7): 1258-1264. 10.1007/s00125-009-1369-9.CrossRefPubMed
19.
go back to reference Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R: IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004, 50 (1): 166-174. 10.1373/clinchem.2003.024802.CrossRefPubMed Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R: IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004, 50 (1): 166-174. 10.1373/clinchem.2003.024802.CrossRefPubMed
20.
go back to reference Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed
21.
go back to reference van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M: Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr. 1993, 70 (1): 47-58. 10.1079/BJN19930104.CrossRefPubMed van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M: Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr. 1993, 70 (1): 47-58. 10.1079/BJN19930104.CrossRefPubMed
22.
go back to reference Clasey JL, Bouchard C, Teates CD, Riblett JE, Thorner MO, Hartman ML, Weltman A: The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res. 1999, 7 (3): 256-264. 10.1002/j.1550-8528.1999.tb00404.x.CrossRefPubMed Clasey JL, Bouchard C, Teates CD, Riblett JE, Thorner MO, Hartman ML, Weltman A: The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res. 1999, 7 (3): 256-264. 10.1002/j.1550-8528.1999.tb00404.x.CrossRefPubMed
23.
go back to reference Pajunen P, Rissanen H, Laaksonen MA, Heliovaara M, Reunanen A, Knekt P: Sagittal Abdominal Diameter as a New Predictor for Incident Diabetes. Diabetes Care. 2013, 36 (2): 283-288. 10.2337/dc11-2451.PubMedCentralCrossRefPubMed Pajunen P, Rissanen H, Laaksonen MA, Heliovaara M, Reunanen A, Knekt P: Sagittal Abdominal Diameter as a New Predictor for Incident Diabetes. Diabetes Care. 2013, 36 (2): 283-288. 10.2337/dc11-2451.PubMedCentralCrossRefPubMed
24.
go back to reference Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed
25.
go back to reference Rittig K, Hieronimus A, Thamer C, Machann J, Peter A, Stock J, Schick F, Fritsche A, Stefan N, Haring HU: Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals. Atherosclerosis. 2010, 212 (2): 575-579. 10.1016/j.atherosclerosis.2010.06.042.CrossRefPubMed Rittig K, Hieronimus A, Thamer C, Machann J, Peter A, Stock J, Schick F, Fritsche A, Stefan N, Haring HU: Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals. Atherosclerosis. 2010, 212 (2): 575-579. 10.1016/j.atherosclerosis.2010.06.042.CrossRefPubMed
26.
go back to reference Barnett KN, Ogston SA, McMurdo ME, Morris AD, Evans JM: A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med. 2010, 27 (10): 1124-1129. 10.1111/j.1464-5491.2010.03075.x.CrossRefPubMed Barnett KN, Ogston SA, McMurdo ME, Morris AD, Evans JM: A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med. 2010, 27 (10): 1124-1129. 10.1111/j.1464-5491.2010.03075.x.CrossRefPubMed
27.
go back to reference Nordhamn K, Sodergren E, Olsson E, Karlstrom B, Vessby B, Berglund L: Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables. Int J Obes Relat Metab Disord. 2000, 24 (5): 652-657. 10.1038/sj.ijo.0801216.CrossRefPubMed Nordhamn K, Sodergren E, Olsson E, Karlstrom B, Vessby B, Berglund L: Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables. Int J Obes Relat Metab Disord. 2000, 24 (5): 652-657. 10.1038/sj.ijo.0801216.CrossRefPubMed
28.
go back to reference Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, Kuk JL, Seidell JC, Snijder MB, Sorensen TI: Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?. Obes Rev. 2008, 9 (4): 312-325. 10.1111/j.1467-789X.2007.00411.x.CrossRefPubMed Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, Kuk JL, Seidell JC, Snijder MB, Sorensen TI: Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?. Obes Rev. 2008, 9 (4): 312-325. 10.1111/j.1467-789X.2007.00411.x.CrossRefPubMed
29.
go back to reference Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008, 31 (4): 811-822. 10.2337/dc08-9018.CrossRefPubMed Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008, 31 (4): 811-822. 10.2337/dc08-9018.CrossRefPubMed
30.
go back to reference Ryoo JH, Park SK: Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: a 5-years’ follow-up study. Atherosclerosis. 2013, 226 (2): 496-501. 10.1016/j.atherosclerosis.2012.11.024.CrossRefPubMed Ryoo JH, Park SK: Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: a 5-years’ follow-up study. Atherosclerosis. 2013, 226 (2): 496-501. 10.1016/j.atherosclerosis.2012.11.024.CrossRefPubMed
31.
go back to reference Cho DS, Woo S, Kim S, Byrne CD, Kong JH, Sung KC: Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults. Cardiovasc Diabetol. 2012, 11: 55-10.1186/1475-2840-11-55.PubMedCentralCrossRefPubMed Cho DS, Woo S, Kim S, Byrne CD, Kong JH, Sung KC: Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults. Cardiovasc Diabetol. 2012, 11: 55-10.1186/1475-2840-11-55.PubMedCentralCrossRefPubMed
32.
go back to reference Holewijn S, Den Heijer M, Swinkels DW, Stalenhoef AF, De Graaf J: Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk. J Intern Med. 2010, 268 (6): 567-577. 10.1111/j.1365-2796.2010.02277.x.CrossRefPubMed Holewijn S, Den Heijer M, Swinkels DW, Stalenhoef AF, De Graaf J: Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk. J Intern Med. 2010, 268 (6): 567-577. 10.1111/j.1365-2796.2010.02277.x.CrossRefPubMed
33.
go back to reference Dehghan A, Van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, Witteman JC: Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care. 2007, 30 (10): 2695-2699. 10.2337/dc07-0348.CrossRefPubMed Dehghan A, Van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, Witteman JC: Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care. 2007, 30 (10): 2695-2699. 10.2337/dc07-0348.CrossRefPubMed
34.
go back to reference An X, Yu D, Zhang R, Zhu J, Du R, Shi Y, Xiong X: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol. 2012, 11: 71-10.1186/1475-2840-11-71.PubMedCentralCrossRefPubMed An X, Yu D, Zhang R, Zhu J, Du R, Shi Y, Xiong X: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol. 2012, 11: 71-10.1186/1475-2840-11-71.PubMedCentralCrossRefPubMed
35.
go back to reference Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001, 358 (9298): 2026-2033. 10.1016/S0140-6736(01)07098-2.CrossRefPubMed Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001, 358 (9298): 2026-2033. 10.1016/S0140-6736(01)07098-2.CrossRefPubMed
36.
go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004, 364 (9438): 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004, 364 (9438): 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed
Metadata
Title
Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes - a prospective observational cohort study
Authors
Elsa M Dahlén
Niclas Bjarnegård
Toste Länne
Fredrik H Nystrom
Carl J Östgren
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-55

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.